# Arcreal

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/arcreal

- Industry: Healthcare IT
- Headquarters: Seoul, South Korea
- Website: www.arcreal.com
- Total disclosed funding: $4.2M
- Latest round: Seed (Oct 18, 2022)
- Investors on record: 5

## About

Based in Seoul, South Korea, and founded in 2021, Arcreal operates as a digital healthcare technology company that develops oral scanners, medical software, and dental platforms. In December 2025, Arcreal raised KRW 8 billion in pre-series A funding from Soo Investment Capital, DSC Investment, SDB Investment, and Schmidt.

The company is working on the digital transformation (DX) of the dental industry with IT technology, by developing intraoral scanners, medical software, and dental platforms, through 3D graphics, artificial intelligence (AI), and software engineering. The company will use the December 2025 funds to accelerate AI model development and establish a US branch as part of its expansion initiatives in the US and Europe.

## Funding rounds

- Seed, Oct 18, 2022, $4.2M — InterVest, DSC Investment, Quantum Ventures Korea, Schmidt, SDB Investment

## Investors

- InterVest (https://capitalatlas.ai/funds/intervest) — Seed
- DSC Investment (https://capitalatlas.ai/funds/dsc-investment) — Seed
- Quantum Ventures Korea (https://capitalatlas.ai/funds/quantum-ventures-korea) — Seed
- Schmidt (https://capitalatlas.ai/funds/schmidt) — Seed
- SDB Investment — Seed